5 results ยท Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Phase 1, First in Human (FIH), Open-Label, Single-Arm, Ascending Dose Study to Assess the Safety, Tolerability and Preliminary Immunogenicity of ITI-9001 in Japanese Patients With Japanese Red Cedar (JRC) PollinosisHypersensitivity, Immediate, Respiratory Hypersensitivity, Rhinitis, Allergic, immune system disorder, nasal disorder, otorhinolaryngologic disease, respiratory system disorder, rhinitis, seasonal allergic rhinitisRecruitingPhase 12026-09-25NCT07726147
J-Valve Transfemoral Pivotal Studyaortic valve disorder, aortic valve insufficiency, cardiovascular disorder, heart disorder, heart valve disorderRecruitingNot applicable2026-05-04NCT06455787
Long-term Safety and Efficacy of ESK-001 in Moderate to Severe Plaque PsoriasisSkin Diseases, Papulosquamous, Skin and Connective Tissue Diseases, psoriasis, skin disorderActive, not recruitingPhase 32026-04-13NCT06846541
Phase 3 Study for Efficacy and Safety Outcomes Data in Japanese Patients With Severe Hemophilia ACongenital, Hereditary, and Neonatal Diseases and Abnormalities, Hemic and Lymphatic Diseases, blood coagulation disease, cardiovascular disorder, coagulation protein disease, hematologic disorder, hemophilia A, hemorrhagic disease, hereditary disease, inherited blood coagulation disorder, vascular disorder, vascular hemostatic diseaseActive, not recruitingPhase 32026-03-19NCT06224907
The Medical Management in Patients Exposed to Weapons of Mass DestructionPulmonary Atelectasis, Respiration Disorders, adult acute respiratory distress syndrome, lung disorder, respiratory system disorderEnrolling by invitationNot stated2025-10-01NCT05026645